

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | chemical homeostasis within a tissue (GO:0048875) | 8.67517448 |
| 2 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 6.88466483 |
| 3 | purine nucleobase biosynthetic process (GO:0009113) | 5.36934609 |
| 4 | regulation of mitochondrial translation (GO:0070129) | 5.24245641 |
| 5 | negative regulation of B cell apoptotic process (GO:0002903) | 5.05005071 |
| 6 | nucleobase biosynthetic process (GO:0046112) | 5.03909598 |
| 7 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 5.03889438 |
| 8 | response to xenobiotic stimulus (GO:0009410) | 4.83161924 |
| 9 | maturation of SSU-rRNA (GO:0030490) | 4.77440467 |
| 10 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 4.72818186 |
| 11 | formation of translation preinitiation complex (GO:0001731) | 4.71345987 |
| 12 | ribosomal small subunit biogenesis (GO:0042274) | 4.64565069 |
| 13 | viral transcription (GO:0019083) | 4.62107123 |
| 14 | translational termination (GO:0006415) | 4.53919171 |
| 15 | negative regulation of mRNA processing (GO:0050686) | 4.44223308 |
| 16 | purine deoxyribonucleotide catabolic process (GO:0009155) | 4.39659806 |
| 17 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.39252182 |
| 18 | ribosomal small subunit assembly (GO:0000028) | 4.29087875 |
| 19 | negative regulation of RNA splicing (GO:0033119) | 4.29030153 |
| 20 | deoxyribose phosphate biosynthetic process (GO:0046385) | 4.25434440 |
| 21 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 4.25434440 |
| 22 | translational initiation (GO:0006413) | 4.20160948 |
| 23 | ribosomal large subunit biogenesis (GO:0042273) | 4.16459759 |
| 24 | establishment of integrated proviral latency (GO:0075713) | 4.13705758 |
| 25 | deoxyribonucleotide catabolic process (GO:0009264) | 4.13545304 |
| 26 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 4.12723565 |
| 27 | intestinal epithelial cell development (GO:0060576) | 4.10338716 |
| 28 | ribosome assembly (GO:0042255) | 4.09194706 |
| 29 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.08679557 |
| 30 | base-excision repair, AP site formation (GO:0006285) | 4.07747182 |
| 31 | transcription from mitochondrial promoter (GO:0006390) | 4.07131629 |
| 32 | exocrine pancreas development (GO:0031017) | 4.06371756 |
| 33 | cotranslational protein targeting to membrane (GO:0006613) | 4.01681582 |
| 34 | protein targeting to ER (GO:0045047) | 4.01640816 |
| 35 | translational elongation (GO:0006414) | 3.99460573 |
| 36 | DNA deamination (GO:0045006) | 3.97904620 |
| 37 | mitotic metaphase plate congression (GO:0007080) | 3.92972242 |
| 38 | deoxyribose phosphate catabolic process (GO:0046386) | 3.86974774 |
| 39 | GMP metabolic process (GO:0046037) | 3.86844162 |
| 40 | protein localization to endoplasmic reticulum (GO:0070972) | 3.82995295 |
| 41 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.80064751 |
| 42 | folic acid metabolic process (GO:0046655) | 3.76819114 |
| 43 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.76570186 |
| 44 | intestinal cholesterol absorption (GO:0030299) | 3.75786286 |
| 45 | oxidative phosphorylation (GO:0006119) | 3.74036907 |
| 46 | protein retention in ER lumen (GO:0006621) | 3.73000018 |
| 47 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.72798336 |
| 48 | pattern specification involved in kidney development (GO:0061004) | 3.69560244 |
| 49 | negative regulation of mRNA metabolic process (GO:1903312) | 3.69531077 |
| 50 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.66651821 |
| 51 | DNA replication checkpoint (GO:0000076) | 3.66022938 |
| 52 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.63220884 |
| 53 | proline biosynthetic process (GO:0006561) | 3.61253206 |
| 54 | ubiquinone biosynthetic process (GO:0006744) | 3.60266047 |
| 55 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.55647994 |
| 56 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.54892841 |
| 57 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.54374052 |
| 58 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.54374052 |
| 59 | NADH dehydrogenase complex assembly (GO:0010257) | 3.54374052 |
| 60 | DNA unwinding involved in DNA replication (GO:0006268) | 3.51052912 |
| 61 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.49089879 |
| 62 | DNA replication initiation (GO:0006270) | 3.45825594 |
| 63 | digestion (GO:0007586) | 3.45383376 |
| 64 | protein complex biogenesis (GO:0070271) | 3.44587135 |
| 65 | viral life cycle (GO:0019058) | 3.43074458 |
| 66 | ribosome biogenesis (GO:0042254) | 3.42182241 |
| 67 | cellular protein complex disassembly (GO:0043624) | 3.42102938 |
| 68 | GTP biosynthetic process (GO:0006183) | 3.39567156 |
| 69 | mitotic recombination (GO:0006312) | 3.38521641 |
| 70 | UV protection (GO:0009650) | 3.37276718 |
| 71 | UTP biosynthetic process (GO:0006228) | 3.36367544 |
| 72 | deoxyribose phosphate metabolic process (GO:0019692) | 3.35966795 |
| 73 | translation (GO:0006412) | 3.35112798 |
| 74 | rRNA processing (GO:0006364) | 3.34196358 |
| 75 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.33465869 |
| 76 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.32678051 |
| 77 | regulation of RIG-I signaling pathway (GO:0039535) | 3.31004996 |
| 78 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.29494390 |
| 79 | cellular response to nitric oxide (GO:0071732) | 3.27548221 |
| 80 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.26747392 |
| 81 | quinone biosynthetic process (GO:1901663) | 3.25645146 |
| 82 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.25115131 |
| 83 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.25013120 |
| 84 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.23890568 |
| 85 | base-excision repair (GO:0006284) | 3.23742687 |
| 86 | rRNA modification (GO:0000154) | 3.23340084 |
| 87 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.23037720 |
| 88 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.22999956 |
| 89 | cytochrome complex assembly (GO:0017004) | 3.21242786 |
| 90 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 3.21202391 |
| 91 | mitochondrial RNA metabolic process (GO:0000959) | 3.21122231 |
| 92 | UTP metabolic process (GO:0046051) | 3.20697356 |
| 93 | establishment of apical/basal cell polarity (GO:0035089) | 3.20375950 |
| 94 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 3.20248618 |
| 95 | establishment of viral latency (GO:0019043) | 3.19694012 |
| 96 | rRNA metabolic process (GO:0016072) | 3.18103644 |
| 97 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.17985371 |
| 98 | viral mRNA export from host cell nucleus (GO:0046784) | 3.17453465 |
| 99 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.16886332 |
| 100 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.16558101 |
| 101 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.16407886 |
| 102 | DNA strand elongation (GO:0022616) | 3.14228040 |
| 103 | lung-associated mesenchyme development (GO:0060484) | 3.13904828 |
| 104 | positive regulation of prostaglandin secretion (GO:0032308) | 3.13748969 |
| 105 | glyoxylate metabolic process (GO:0046487) | 3.13232084 |
| 106 | termination of RNA polymerase III transcription (GO:0006386) | 3.12577965 |
| 107 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.12577965 |
| 108 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.10917096 |
| 109 | regulation of B cell apoptotic process (GO:0002902) | 3.09691519 |
| 110 | regulation of translation in response to stress (GO:0043555) | 3.08987122 |
| 111 | ubiquinone metabolic process (GO:0006743) | 3.08344823 |
| 112 | deoxyribonucleotide metabolic process (GO:0009262) | 3.07992440 |
| 113 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 3.07405875 |
| 114 | response to peptidoglycan (GO:0032494) | 3.05029383 |
| 115 | estrogen biosynthetic process (GO:0006703) | 3.04163447 |
| 116 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.02355653 |
| 117 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.01786587 |
| 118 | negative regulation of cell aging (GO:0090344) | 3.01575704 |
| 119 | translesion synthesis (GO:0019985) | 3.00833775 |
| 120 | aerobic respiration (GO:0009060) | 3.00378754 |
| 121 | pentose metabolic process (GO:0019321) | 3.00338418 |
| 122 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.98583940 |
| 123 | L-serine metabolic process (GO:0006563) | 2.98421716 |
| 124 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.96833038 |
| 125 | GDP-mannose metabolic process (GO:0019673) | 2.96583178 |
| 126 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.95174516 |
| 127 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.94847948 |
| 128 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.93933391 |
| 129 | lung secretory cell differentiation (GO:0061140) | 2.93490896 |
| 130 | protein complex disassembly (GO:0043241) | 2.93190776 |
| 131 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.92446987 |
| 132 | serine family amino acid biosynthetic process (GO:0009070) | 2.90569082 |
| 133 | definitive hemopoiesis (GO:0060216) | 2.90157618 |
| 134 | amino acid salvage (GO:0043102) | 2.87552179 |
| 135 | L-methionine salvage (GO:0071267) | 2.87552179 |
| 136 | L-methionine biosynthetic process (GO:0071265) | 2.87552179 |
| 137 | regulation of spindle organization (GO:0090224) | 2.87282671 |
| 138 | metaphase plate congression (GO:0051310) | 2.86850783 |
| 139 | mature B cell differentiation involved in immune response (GO:0002313) | 2.83540246 |
| 140 | glycine metabolic process (GO:0006544) | 2.83226663 |
| 141 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.82837654 |
| 142 | protein localization to kinetochore (GO:0034501) | 2.81909809 |
| 143 | spliceosomal snRNP assembly (GO:0000387) | 2.79542572 |
| 144 | grooming behavior (GO:0007625) | 2.79305190 |
| 145 | macrophage differentiation (GO:0030225) | 2.79084763 |
| 146 | Peyers patch development (GO:0048541) | 2.78993894 |
| 147 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.78993894 |
| 148 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.78526067 |
| 149 | cysteine metabolic process (GO:0006534) | 2.77351119 |
| 150 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.76422443 |
| 151 | negative regulation of cell cycle arrest (GO:0071157) | 2.75361442 |
| 152 | proline metabolic process (GO:0006560) | 2.74635739 |
| 153 | polyamine biosynthetic process (GO:0006596) | 2.74417632 |
| 154 | pseudouridine synthesis (GO:0001522) | 2.73950416 |
| 155 | cellular component biogenesis (GO:0044085) | 2.73892881 |
| 156 | endothelial tube morphogenesis (GO:0061154) | 2.73291368 |
| 157 | morphogenesis of an endothelium (GO:0003159) | 2.73291368 |
| 158 | macromolecular complex disassembly (GO:0032984) | 2.72478239 |
| 159 | protein maturation by protein folding (GO:0022417) | 2.72474214 |
| 160 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.70974607 |
| 161 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.68011218 |
| 162 | protein targeting to membrane (GO:0006612) | 2.67991802 |
| 163 | mRNA catabolic process (GO:0006402) | 2.67477368 |
| 164 | transcription from RNA polymerase I promoter (GO:0006360) | 2.66988933 |
| 165 | telomere maintenance via recombination (GO:0000722) | 2.66147234 |
| 166 | RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502) | 2.63069269 |
| 167 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.62698704 |
| 168 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.61959418 |
| 169 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253) | 2.61416451 |
| 170 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.60535132 |
| 171 | positive regulation of chromosome segregation (GO:0051984) | 2.60482176 |
| 172 | RNA catabolic process (GO:0006401) | 2.60440381 |
| 173 | surfactant homeostasis (GO:0043129) | 10.8678636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.59075778 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.50580378 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.75304511 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.59081155 |
| 5 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.39352503 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.21021731 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.08620252 |
| 8 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.93477742 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.93460955 |
| 10 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.74003459 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.73264360 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.69746340 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.68752304 |
| 14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.68344404 |
| 15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.49459448 |
| 16 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.40151077 |
| 17 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.37934505 |
| 18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.18894793 |
| 19 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.18645911 |
| 20 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.15620086 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.03948269 |
| 22 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.01377883 |
| 23 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.98705766 |
| 24 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.96296737 |
| 25 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.96296737 |
| 26 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.96296737 |
| 27 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.94048655 |
| 28 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.93204618 |
| 29 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.92600503 |
| 30 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.92086190 |
| 31 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.79534905 |
| 32 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.79150084 |
| 33 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.75546856 |
| 34 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.73441175 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.73194439 |
| 36 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.72385477 |
| 37 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.70849843 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.69591578 |
| 39 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.68191461 |
| 40 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.66649486 |
| 41 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.66529339 |
| 42 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.66321924 |
| 43 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64847136 |
| 44 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.64227125 |
| 45 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.62249770 |
| 46 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.58937670 |
| 47 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.56778214 |
| 48 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.55218647 |
| 49 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.54267955 |
| 50 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.53991492 |
| 51 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.53551473 |
| 52 | P68_20966046_ChIP-Seq_HELA_Human | 1.51531525 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50565029 |
| 54 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.49073953 |
| 55 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48151727 |
| 56 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.46655021 |
| 57 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.46290503 |
| 58 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.40185917 |
| 59 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.39920615 |
| 60 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.38983463 |
| 61 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.37963849 |
| 62 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.37818317 |
| 63 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.37682670 |
| 64 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.36868464 |
| 65 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.35748074 |
| 66 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.35160671 |
| 67 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.34616221 |
| 68 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.34574489 |
| 69 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.33125472 |
| 70 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.32975030 |
| 71 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.32925819 |
| 72 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.31541901 |
| 73 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.31104809 |
| 74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29820853 |
| 75 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.29466936 |
| 76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.28762839 |
| 77 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.28464584 |
| 78 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.28281472 |
| 79 | UTX_26944678_Chip-Seq_JUKART_Human | 1.25478742 |
| 80 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.25078937 |
| 81 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.25050736 |
| 82 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.24722829 |
| 83 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.23557745 |
| 84 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.22646925 |
| 85 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.21365120 |
| 86 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.21281537 |
| 87 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19892855 |
| 88 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.19643082 |
| 89 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19548467 |
| 90 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19495342 |
| 91 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.18670080 |
| 92 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.18653281 |
| 93 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.17921543 |
| 94 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.17081614 |
| 95 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16624801 |
| 96 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.16356409 |
| 97 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15660563 |
| 98 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.15497204 |
| 99 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.15399898 |
| 100 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.14575351 |
| 101 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.14471699 |
| 102 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.14250962 |
| 103 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.14181099 |
| 104 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.13697925 |
| 105 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.13380268 |
| 106 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.12789304 |
| 107 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.12620659 |
| 108 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.11628705 |
| 109 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.10999648 |
| 110 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.10792516 |
| 111 | MAF_26560356_Chip-Seq_TH2_Human | 1.10275948 |
| 112 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.10143870 |
| 113 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10090371 |
| 114 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09907213 |
| 115 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.09038315 |
| 116 | MYC_22102868_ChIP-Seq_BL_Human | 1.08377200 |
| 117 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.08141028 |
| 118 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07919098 |
| 119 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.07470477 |
| 120 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.06953471 |
| 121 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.06922691 |
| 122 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.06544697 |
| 123 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.06470503 |
| 124 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05909973 |
| 125 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.03665477 |
| 126 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.03274413 |
| 127 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.03103633 |
| 128 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.02521267 |
| 129 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.02299600 |
| 130 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.97643039 |
| 131 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95962424 |
| 132 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.95444664 |
| 133 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.95337199 |
| 134 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.94921300 |
| 135 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.93776255 |
| 136 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.93692441 |
| 137 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.93222431 |
| 138 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93148434 |
| 139 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.93074551 |
| 140 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.90707831 |
| 141 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.87902019 |
| 142 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.87778978 |
| 143 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.87462479 |
| 144 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.86363446 |
| 145 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.85305508 |
| 146 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84987576 |
| 147 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.84278983 |
| 148 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.83662954 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004782_abnormal_surfactant_physiolog | 7.63281002 |
| 2 | MP0005083_abnormal_biliary_tract | 5.98795463 |
| 3 | MP0008995_early_reproductive_senescence | 4.15734325 |
| 4 | MP0003693_abnormal_embryo_hatching | 3.58386333 |
| 5 | MP0001958_emphysema | 3.25446188 |
| 6 | MP0001666_abnormal_nutrient_absorption | 3.21040084 |
| 7 | MP0004957_abnormal_blastocyst_morpholog | 3.08504215 |
| 8 | MP0008004_abnormal_stomach_pH | 2.97446236 |
| 9 | MP0005220_abnormal_exocrine_pancreas | 2.71053866 |
| 10 | MP0003786_premature_aging | 2.60579125 |
| 11 | MP0004808_abnormal_hematopoietic_stem | 2.58018571 |
| 12 | MP0003303_peritoneal_inflammation | 2.55547899 |
| 13 | MP0002822_catalepsy | 2.36704851 |
| 14 | MP0006036_abnormal_mitochondrial_physio | 2.36597579 |
| 15 | MP0002234_abnormal_pharynx_morphology | 2.26694978 |
| 16 | MP0003111_abnormal_nucleus_morphology | 2.09855236 |
| 17 | MP0010368_abnormal_lymphatic_system | 1.99867580 |
| 18 | MP0010094_abnormal_chromosome_stability | 1.98218491 |
| 19 | MP0003724_increased_susceptibility_to | 1.90562878 |
| 20 | MP0003718_maternal_effect | 1.90401292 |
| 21 | MP0009697_abnormal_copulation | 1.89291540 |
| 22 | MP0002132_abnormal_respiratory_system | 1.82645208 |
| 23 | MP0000015_abnormal_ear_pigmentation | 1.82575548 |
| 24 | MP0003077_abnormal_cell_cycle | 1.82343560 |
| 25 | MP0001177_atelectasis | 1.81578603 |
| 26 | MP0002277_abnormal_respiratory_mucosa | 1.78334580 |
| 27 | MP0009840_abnormal_foam_cell | 1.77538291 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.76225816 |
| 29 | MP0005388_respiratory_system_phenotype | 1.75406977 |
| 30 | MP0002133_abnormal_respiratory_system | 1.75406977 |
| 31 | MP0001730_embryonic_growth_arrest | 1.74706331 |
| 32 | MP0005084_abnormal_gallbladder_morpholo | 1.70928828 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.66821308 |
| 34 | MP0005408_hypopigmentation | 1.63953274 |
| 35 | MP0005365_abnormal_bile_salt | 1.63538782 |
| 36 | MP0005075_abnormal_melanosome_morpholog | 1.59768595 |
| 37 | MP0005085_abnormal_gallbladder_physiolo | 1.58989552 |
| 38 | MP0003436_decreased_susceptibility_to | 1.58431861 |
| 39 | MP0004147_increased_porphyrin_level | 1.53200607 |
| 40 | MP0005360_urolithiasis | 1.51666853 |
| 41 | MP0002160_abnormal_reproductive_system | 1.51321902 |
| 42 | MP0010030_abnormal_orbit_morphology | 1.47225041 |
| 43 | MP0001881_abnormal_mammary_gland | 1.43339563 |
| 44 | MP0000490_abnormal_crypts_of | 1.40028051 |
| 45 | MP0005666_abnormal_adipose_tissue | 1.39700480 |
| 46 | MP0005076_abnormal_cell_differentiation | 1.39331607 |
| 47 | MP0003123_paternal_imprinting | 1.37381087 |
| 48 | MP0002295_abnormal_pulmonary_circulatio | 1.36763685 |
| 49 | MP0008057_abnormal_DNA_replication | 1.31451644 |
| 50 | MP0002398_abnormal_bone_marrow | 1.29584830 |
| 51 | MP0002970_abnormal_white_adipose | 1.29546470 |
| 52 | MP0003186_abnormal_redox_activity | 1.29269889 |
| 53 | MP0002722_abnormal_immune_system | 1.27507455 |
| 54 | MP0001664_abnormal_digestion | 1.26649258 |
| 55 | MP0001764_abnormal_homeostasis | 1.25015343 |
| 56 | MP0005025_abnormal_response_to | 1.23686414 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.22894427 |
| 58 | MP0003763_abnormal_thymus_physiology | 1.22713596 |
| 59 | MP0005330_cardiomyopathy | 1.21514942 |
| 60 | MP0002971_abnormal_brown_adipose | 1.20959246 |
| 61 | MP0005375_adipose_tissue_phenotype | 1.19143264 |
| 62 | MP0003806_abnormal_nucleotide_metabolis | 1.16971255 |
| 63 | MP0000350_abnormal_cell_proliferation | 1.16085108 |
| 64 | MP0004264_abnormal_extraembryonic_tissu | 1.15488300 |
| 65 | MP0002396_abnormal_hematopoietic_system | 1.15479293 |
| 66 | MP0008873_increased_physiological_sensi | 1.13947869 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.11567654 |
| 68 | MP0000678_abnormal_parathyroid_gland | 1.08857951 |
| 69 | MP0010352_gastrointestinal_tract_polyps | 1.08031000 |
| 70 | MP0000689_abnormal_spleen_morphology | 1.07760197 |
| 71 | MP0008875_abnormal_xenobiotic_pharmacok | 1.07283133 |
| 72 | MP0005623_abnormal_meninges_morphology | 1.06176960 |
| 73 | MP0000750_abnormal_muscle_regeneration | 1.04545922 |
| 74 | MP0002429_abnormal_blood_cell | 1.04296509 |
| 75 | MP0003943_abnormal_hepatobiliary_system | 1.04209987 |
| 76 | MP0000537_abnormal_urethra_morphology | 1.01666971 |
| 77 | MP0001853_heart_inflammation | 1.00323724 |
| 78 | MP0008260_abnormal_autophagy | 1.00244724 |
| 79 | MP0003567_abnormal_fetal_cardiomyocyte | 1.00235007 |
| 80 | MP0002080_prenatal_lethality | 0.99627429 |
| 81 | MP0003638_abnormal_response/metabolism_ | 0.99397324 |
| 82 | MP0006035_abnormal_mitochondrial_morpho | 0.98193483 |
| 83 | MP0005058_abnormal_lysosome_morphology | 0.98169859 |
| 84 | MP0000703_abnormal_thymus_morphology | 0.94889810 |
| 85 | MP0002086_abnormal_extraembryonic_tissu | 0.93817996 |
| 86 | MP0001697_abnormal_embryo_size | 0.93592188 |
| 87 | MP0008932_abnormal_embryonic_tissue | 0.90789547 |
| 88 | MP0005380_embryogenesis_phenotype | 0.90762290 |
| 89 | MP0001672_abnormal_embryogenesis/_devel | 0.90762290 |
| 90 | MP0000681_abnormal_thyroid_gland | 0.90705447 |
| 91 | MP0001545_abnormal_hematopoietic_system | 0.90634406 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 0.90634406 |
| 93 | MP0005266_abnormal_metabolism | 0.90473835 |
| 94 | MP0008058_abnormal_DNA_repair | 0.89607331 |
| 95 | MP0002098_abnormal_vibrissa_morphology | 0.89438495 |
| 96 | MP0005636_abnormal_mineral_homeostasis | 0.88920827 |
| 97 | MP0005501_abnormal_skin_physiology | 0.88723426 |
| 98 | MP0008007_abnormal_cellular_replicative | 0.88651525 |
| 99 | MP0000716_abnormal_immune_system | 0.88375042 |
| 100 | MP0005451_abnormal_body_composition | 0.88123498 |
| 101 | MP0005334_abnormal_fat_pad | 0.86598262 |
| 102 | MP0004272_abnormal_basement_membrane | 0.85954106 |
| 103 | MP0009379_abnormal_foot_pigmentation | 0.84697098 |
| 104 | MP0009384_cardiac_valve_regurgitation | 0.84350911 |
| 105 | MP0005499_abnormal_olfactory_system | 0.84110371 |
| 106 | MP0005394_taste/olfaction_phenotype | 0.84110371 |
| 107 | MP0002420_abnormal_adaptive_immunity | 0.83458842 |
| 108 | MP0002085_abnormal_embryonic_tissue | 0.83374001 |
| 109 | MP0003315_abnormal_perineum_morphology | 0.82853536 |
| 110 | MP0002138_abnormal_hepatobiliary_system | 0.82613978 |
| 111 | MP0002148_abnormal_hypersensitivity_rea | 0.82229235 |
| 112 | MP0002419_abnormal_innate_immunity | 0.81293692 |
| 113 | MP0003984_embryonic_growth_retardation | 0.81094808 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 0.80498903 |
| 115 | MP0001879_abnormal_lymphatic_vessel | 0.80444136 |
| 116 | MP0003119_abnormal_digestive_system | 0.80130917 |
| 117 | MP0001819_abnormal_immune_cell | 0.80064758 |
| 118 | MP0001905_abnormal_dopamine_level | 0.79855778 |
| 119 | MP0002796_impaired_skin_barrier | 0.79438838 |
| 120 | MP0000566_synostosis | 0.79326162 |
| 121 | MP0000598_abnormal_liver_morphology | 0.79205208 |
| 122 | MP0002019_abnormal_tumor_incidence | 0.78638928 |
| 123 | MP0009278_abnormal_bone_marrow | 0.78014740 |
| 124 | MP0002088_abnormal_embryonic_growth/wei | 0.77808686 |
| 125 | MP0008872_abnormal_physiological_respon | 0.76852001 |
| 126 | MP0001175_abnormal_lung_morphology | 0.76760376 |
| 127 | MP0000470_abnormal_stomach_morphology | 0.76695276 |
| 128 | MP0002405_respiratory_system_inflammati | 0.76405636 |
| 129 | MP0005023_abnormal_wound_healing | 0.76311384 |
| 130 | MP0003866_abnormal_defecation | 0.74855240 |
| 131 | MP0000465_gastrointestinal_hemorrhage | 0.74206882 |
| 132 | MP0005670_abnormal_white_adipose | 0.73898644 |
| 133 | MP0001849_ear_inflammation | 0.73669792 |
| 134 | MP0005332_abnormal_amino_acid | 0.71657152 |
| 135 | MP0005319_abnormal_enzyme/_coenzyme | 0.71653789 |
| 136 | MP0001851_eye_inflammation | 0.71595983 |
| 137 | MP0003075_altered_response_to | 0.71462994 |
| 138 | MP0002118_abnormal_lipid_homeostasis | 0.70241041 |
| 139 | MP0005165_increased_susceptibility_to | 0.69808853 |
| 140 | MP0008469_abnormal_protein_level | 0.69166432 |
| 141 | MP0000313_abnormal_cell_death | 0.69146064 |
| 142 | MP0008961_abnormal_basal_metabolism | 0.67992412 |
| 143 | MP0000358_abnormal_cell_content/ | 0.67585167 |
| 144 | MP0002693_abnormal_pancreas_physiology | 0.67349023 |
| 145 | MP0004197_abnormal_fetal_growth/weight/ | 0.66531478 |
| 146 | MP0003172_abnormal_lysosome_physiology | 0.65830193 |
| 147 | MP0000003_abnormal_adipose_tissue | 0.65797790 |
| 148 | MP0002095_abnormal_skin_pigmentation | 0.64840419 |
| 149 | MP0002084_abnormal_developmental_patter | 0.64086340 |
| 150 | MP0001145_abnormal_male_reproductive | 0.63412617 |
| 151 | MP0006292_abnormal_olfactory_placode | 0.63339860 |
| 152 | MP0001542_abnormal_bone_strength | 0.62375438 |
| 153 | MP0009333_abnormal_splenocyte_physiolog | 0.61948513 |
| 154 | MP0003448_altered_tumor_morphology | 0.60298277 |
| 155 | MP0000627_abnormal_mammary_gland | 0.58373274 |
| 156 | MP0003705_abnormal_hypodermis_morpholog | 0.57565517 |
| 157 | MP0004185_abnormal_adipocyte_glucose | 0.56918524 |
| 158 | MP0003868_abnormal_feces_composition | 0.56372630 |
| 159 | MP0009643_abnormal_urine_homeostasis | 0.55963213 |
| 160 | MP0005395_other_phenotype | 0.55753337 |
| 161 | MP0001873_stomach_inflammation | 0.53447011 |
| 162 | MP0000462_abnormal_digestive_system | 0.52982403 |
| 163 | MP0003115_abnormal_respiratory_system | 0.52266145 |
| 164 | MP0010678_abnormal_skin_adnexa | 0.51804217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gout (HP:0001997) | 6.79239770 |
| 2 | Hepatocellular necrosis (HP:0001404) | 5.35343536 |
| 3 | Hepatic necrosis (HP:0002605) | 4.78551054 |
| 4 | Tubulointerstitial fibrosis (HP:0005576) | 4.76202111 |
| 5 | Tachypnea (HP:0002789) | 4.59224444 |
| 6 | Renal salt wasting (HP:0000127) | 4.58678086 |
| 7 | Thrombocytosis (HP:0001894) | 4.57135449 |
| 8 | Respiratory distress (HP:0002098) | 4.41586581 |
| 9 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.93039920 |
| 10 | Ragged-red muscle fibers (HP:0003200) | 3.92543306 |
| 11 | Tubulointerstitial nephritis (HP:0001970) | 3.91073649 |
| 12 | Microvesicular hepatic steatosis (HP:0001414) | 3.86910199 |
| 13 | Mitochondrial inheritance (HP:0001427) | 3.85539120 |
| 14 | Congenital, generalized hypertrichosis (HP:0004540) | 3.85345923 |
| 15 | Carpal bone hypoplasia (HP:0001498) | 3.84668933 |
| 16 | Stenosis of the external auditory canal (HP:0000402) | 3.83211895 |
| 17 | Chronic bronchitis (HP:0004469) | 3.82249122 |
| 18 | Birth length less than 3rd percentile (HP:0003561) | 3.79780532 |
| 19 | Reticulocytopenia (HP:0001896) | 3.78540426 |
| 20 | Breast hypoplasia (HP:0003187) | 3.76138343 |
| 21 | Type I transferrin isoform profile (HP:0003642) | 3.73919984 |
| 22 | Increased muscle lipid content (HP:0009058) | 3.63277114 |
| 23 | Abnormal number of erythroid precursors (HP:0012131) | 3.51076216 |
| 24 | Hyperactive renin-angiotensin system (HP:0000841) | 3.51035135 |
| 25 | Increased intramyocellular lipid droplets (HP:0012240) | 3.46656780 |
| 26 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.40382915 |
| 27 | Increased CSF lactate (HP:0002490) | 3.35173414 |
| 28 | Acute encephalopathy (HP:0006846) | 3.21640548 |
| 29 | Hyperglycinemia (HP:0002154) | 3.15682636 |
| 30 | Acute necrotizing encephalopathy (HP:0006965) | 3.09592049 |
| 31 | Increased serum ferritin (HP:0003281) | 3.07983182 |
| 32 | Cerebral hypomyelination (HP:0006808) | 3.05926574 |
| 33 | Dicarboxylic aciduria (HP:0003215) | 3.01465701 |
| 34 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.01465701 |
| 35 | Hyperuricemia (HP:0002149) | 2.93116262 |
| 36 | Increased purine levels (HP:0004368) | 2.93116262 |
| 37 | Macrocytic anemia (HP:0001972) | 2.92436425 |
| 38 | Abnormality of the umbilical cord (HP:0010881) | 2.91958091 |
| 39 | Abnormal protein glycosylation (HP:0012346) | 2.91282147 |
| 40 | Abnormal glycosylation (HP:0012345) | 2.91282147 |
| 41 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.91282147 |
| 42 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.91282147 |
| 43 | Rough bone trabeculation (HP:0100670) | 2.91252658 |
| 44 | Visual hallucinations (HP:0002367) | 2.90246783 |
| 45 | Lipid accumulation in hepatocytes (HP:0006561) | 2.88134702 |
| 46 | Rhabdomyolysis (HP:0003201) | 2.87738581 |
| 47 | Onycholysis (HP:0001806) | 2.87333258 |
| 48 | Agammaglobulinemia (HP:0004432) | 2.86592365 |
| 49 | Increased serum lactate (HP:0002151) | 2.80274421 |
| 50 | Microretrognathia (HP:0000308) | 2.78964653 |
| 51 | Lactic acidosis (HP:0003128) | 2.75328845 |
| 52 | Acute lymphatic leukemia (HP:0006721) | 2.74548897 |
| 53 | Split foot (HP:0001839) | 2.74458354 |
| 54 | Tubulointerstitial abnormality (HP:0001969) | 2.73921563 |
| 55 | Abnormality of the prostate (HP:0008775) | 2.71276067 |
| 56 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.71169664 |
| 57 | Increased hepatocellular lipid droplets (HP:0006565) | 2.71140343 |
| 58 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.70291274 |
| 59 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.70291274 |
| 60 | Chronic obstructive pulmonary disease (HP:0006510) | 2.69435955 |
| 61 | Obstructive lung disease (HP:0006536) | 2.69435955 |
| 62 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.69420112 |
| 63 | Tubular atrophy (HP:0000092) | 2.69170048 |
| 64 | Growth hormone excess (HP:0000845) | 2.68453571 |
| 65 | Broad metatarsal (HP:0001783) | 2.67865612 |
| 66 | Petechiae (HP:0000967) | 2.62368371 |
| 67 | Progressive muscle weakness (HP:0003323) | 2.59116512 |
| 68 | Oral leukoplakia (HP:0002745) | 2.57567577 |
| 69 | Exercise intolerance (HP:0003546) | 2.56569929 |
| 70 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.54454863 |
| 71 | Single umbilical artery (HP:0001195) | 2.54454863 |
| 72 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.54454863 |
| 73 | Emotional lability (HP:0000712) | 2.54216062 |
| 74 | Polycythemia (HP:0001901) | 2.54143838 |
| 75 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.51170867 |
| 76 | Recurrent cutaneous fungal infections (HP:0011370) | 2.51170867 |
| 77 | B lymphocytopenia (HP:0010976) | 2.50695745 |
| 78 | Prolonged neonatal jaundice (HP:0006579) | 2.50219047 |
| 79 | Cerebral palsy (HP:0100021) | 2.49747734 |
| 80 | Cerebral edema (HP:0002181) | 2.47237725 |
| 81 | Achilles tendon contracture (HP:0001771) | 2.46647385 |
| 82 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.46517747 |
| 83 | Abnormality of iron homeostasis (HP:0011031) | 2.46485442 |
| 84 | Abnormality of the Achilles tendon (HP:0005109) | 2.44938192 |
| 85 | Recurrent fungal infections (HP:0002841) | 2.44879168 |
| 86 | Pustule (HP:0200039) | 2.43844748 |
| 87 | Granulocytopenia (HP:0001913) | 2.43809691 |
| 88 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.41617947 |
| 89 | Pallor (HP:0000980) | 2.40736490 |
| 90 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.39064327 |
| 91 | Cellulitis (HP:0100658) | 2.39045170 |
| 92 | Pancytopenia (HP:0001876) | 2.38458602 |
| 93 | Ureteral duplication (HP:0000073) | 2.37981362 |
| 94 | Hypertensive crisis (HP:0100735) | 2.36003390 |
| 95 | Renal Fanconi syndrome (HP:0001994) | 2.33653448 |
| 96 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.33228635 |
| 97 | Multiple enchondromatosis (HP:0005701) | 2.27947694 |
| 98 | Steatorrhea (HP:0002570) | 2.25938346 |
| 99 | Short hallux (HP:0010109) | 2.24899641 |
| 100 | Severe visual impairment (HP:0001141) | 2.23890864 |
| 101 | Hyperammonemia (HP:0001987) | 2.23347386 |
| 102 | Hypergonadotropic hypogonadism (HP:0000815) | 2.22787907 |
| 103 | Hypotension (HP:0002615) | 2.22472478 |
| 104 | Absent radius (HP:0003974) | 2.21937610 |
| 105 | Patellar aplasia (HP:0006443) | 2.21466441 |
| 106 | Premature skin wrinkling (HP:0100678) | 2.21173442 |
| 107 | Mediastinal lymphadenopathy (HP:0100721) | 2.20967267 |
| 108 | Premature ovarian failure (HP:0008209) | 2.20665783 |
| 109 | Reduced antithrombin III activity (HP:0001976) | 2.20183557 |
| 110 | Abnormality of B cell number (HP:0010975) | 2.18876409 |
| 111 | Short chin (HP:0000331) | 2.18695583 |
| 112 | Skin rash (HP:0000988) | 2.18426949 |
| 113 | Progressive macrocephaly (HP:0004481) | 2.18275055 |
| 114 | Aplastic anemia (HP:0001915) | 2.18065810 |
| 115 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.16021510 |
| 116 | Abnormal hemoglobin (HP:0011902) | 2.14067541 |
| 117 | Abnormality of the parathyroid morphology (HP:0011766) | 2.12790913 |
| 118 | Panhypogammaglobulinemia (HP:0003139) | 2.11800305 |
| 119 | Glomerulosclerosis (HP:0000096) | 2.09772328 |
| 120 | Absent forearm bone (HP:0003953) | 2.08029874 |
| 121 | Aplasia involving forearm bones (HP:0009822) | 2.08029874 |
| 122 | Stomach cancer (HP:0012126) | 2.06414886 |
| 123 | Neurofibrillary tangles (HP:0002185) | 2.06349294 |
| 124 | Hyperglycinuria (HP:0003108) | 2.06347352 |
| 125 | Lethargy (HP:0001254) | 2.06282604 |
| 126 | Pili torti (HP:0003777) | 2.06102097 |
| 127 | Thoracic kyphosis (HP:0002942) | 2.05979798 |
| 128 | Selective tooth agenesis (HP:0001592) | 2.05969790 |
| 129 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.05801048 |
| 130 | Opisthotonus (HP:0002179) | 2.05287584 |
| 131 | Neonatal respiratory distress (HP:0002643) | 2.05125272 |
| 132 | Hypertriglyceridemia (HP:0002155) | 2.05117009 |
| 133 | Colon cancer (HP:0003003) | 2.04769504 |
| 134 | Exercise-induced myalgia (HP:0003738) | 2.04739286 |
| 135 | Hyponatremia (HP:0002902) | 2.04542295 |
| 136 | Degeneration of anterior horn cells (HP:0002398) | 2.04194291 |
| 137 | Abnormality of the anterior horn cell (HP:0006802) | 2.04194291 |
| 138 | Dry hair (HP:0011359) | 2.03646309 |
| 139 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.03243707 |
| 140 | Spastic paraparesis (HP:0002313) | 2.02805647 |
| 141 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.01159427 |
| 142 | Interstitial pulmonary disease (HP:0006530) | 10.4147257 |
| 143 | Testicular atrophy (HP:0000029) | 1.99619034 |
| 144 | Epistaxis (HP:0000421) | 1.99494192 |
| 145 | Secondary amenorrhea (HP:0000869) | 1.98625851 |
| 146 | Trismus (HP:0000211) | 1.98490385 |
| 147 | Glossoptosis (HP:0000162) | 1.98129072 |
| 148 | Abnormality of male internal genitalia (HP:0000022) | 1.98057617 |
| 149 | Patent foramen ovale (HP:0001655) | 1.97854357 |
| 150 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.97791119 |
| 151 | Abnormal trabecular bone morphology (HP:0100671) | 1.96528773 |
| 152 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.95556898 |
| 153 | Failure to thrive in infancy (HP:0001531) | 1.93846562 |
| 154 | Ulnar bowing (HP:0003031) | 1.93685489 |
| 155 | Sparse eyelashes (HP:0000653) | 1.93530793 |
| 156 | Absent thumb (HP:0009777) | 1.92780645 |
| 157 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.92694178 |
| 158 | Osteolytic defects of the hand bones (HP:0009699) | 1.92694178 |
| 159 | Personality changes (HP:0000751) | 1.91533726 |
| 160 | Metabolic acidosis (HP:0001942) | 1.91415086 |
| 161 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.91236928 |
| 162 | Abnormality of glycine metabolism (HP:0010895) | 1.91236928 |
| 163 | Prostate neoplasm (HP:0100787) | 1.91175910 |
| 164 | Abnormality of the labia minora (HP:0012880) | 1.90103456 |
| 165 | Seborrheic dermatitis (HP:0001051) | 1.88249127 |
| 166 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.87500553 |
| 167 | Meningitis (HP:0001287) | 1.87040585 |
| 168 | Bronchitis (HP:0012387) | 1.85517330 |
| 169 | Fatigue (HP:0012378) | 1.85403953 |
| 170 | Impulsivity (HP:0100710) | 1.82736898 |
| 171 | Respiratory failure (HP:0002878) | 1.82511200 |
| 172 | Decreased subcutaneous fat (HP:0001002) | 1.82051971 |
| 173 | Ventricular fibrillation (HP:0001663) | 1.80511965 |
| 174 | Thyroid-stimulating hormone excess (HP:0002925) | 1.79139971 |
| 175 | Broad distal phalanx of finger (HP:0009836) | 1.77062131 |
| 176 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.76351946 |
| 177 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.74757559 |
| 178 | Neoplasm of the pancreas (HP:0002894) | 1.72177721 |
| 179 | Absent toe (HP:0010760) | 1.70692084 |
| 180 | Death in infancy (HP:0001522) | 1.70000308 |
| 181 | Hematochezia (HP:0002573) | 1.66591517 |
| 182 | Abnormality of the nasal mucosa (HP:0000433) | 1.65511770 |
| 183 | CNS hypomyelination (HP:0003429) | 1.65202800 |
| 184 | Atresia of the external auditory canal (HP:0000413) | 1.65078924 |
| 185 | Conjunctival telangiectasia (HP:0000524) | 1.63809068 |
| 186 | Fragile nails (HP:0001808) | 1.63538608 |
| 187 | Bowed forearm bones (HP:0003956) | 1.62445862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.23394516 |
| 2 | TESK2 | 4.75673764 |
| 3 | BUB1 | 4.44554550 |
| 4 | BCKDK | 3.32147225 |
| 5 | WEE1 | 3.07652626 |
| 6 | EPHA2 | 2.84153286 |
| 7 | NME2 | 2.80383478 |
| 8 | STK24 | 2.69425415 |
| 9 | TSSK6 | 2.58339757 |
| 10 | ZAP70 | 2.45780751 |
| 11 | PAK4 | 2.40440835 |
| 12 | MAP2K2 | 2.20294156 |
| 13 | LRRK2 | 2.20075881 |
| 14 | TIE1 | 2.14635468 |
| 15 | MST4 | 2.09142663 |
| 16 | SMG1 | 1.93421038 |
| 17 | PIM2 | 1.93105618 |
| 18 | VRK1 | 1.91571667 |
| 19 | NEK2 | 1.91214298 |
| 20 | CDC7 | 1.87884291 |
| 21 | ILK | 1.86928578 |
| 22 | TAOK2 | 1.85608944 |
| 23 | NUAK1 | 1.80302840 |
| 24 | STK16 | 1.77016673 |
| 25 | SRPK1 | 1.69842929 |
| 26 | EIF2AK3 | 1.64650344 |
| 27 | PLK1 | 1.61882603 |
| 28 | CDK12 | 1.60289944 |
| 29 | TRIB3 | 1.56949380 |
| 30 | PLK4 | 1.55765177 |
| 31 | ERN1 | 1.51337600 |
| 32 | FGFR2 | 1.43709668 |
| 33 | MAP4K1 | 1.41858313 |
| 34 | RPS6KA4 | 1.40631352 |
| 35 | PLK3 | 1.38888036 |
| 36 | DYRK3 | 1.37617966 |
| 37 | IRAK3 | 1.37586189 |
| 38 | FLT3 | 1.37263025 |
| 39 | TAOK3 | 1.37152547 |
| 40 | STK10 | 1.32910442 |
| 41 | AURKB | 1.32606243 |
| 42 | KIT | 1.32192453 |
| 43 | MYLK | 1.24861669 |
| 44 | MAPK15 | 1.23235015 |
| 45 | MAP3K11 | 1.19050628 |
| 46 | MAP3K8 | 1.19050494 |
| 47 | CDK7 | 1.16525676 |
| 48 | MKNK2 | 1.13758024 |
| 49 | AKT3 | 1.13215687 |
| 50 | CDK6 | 1.12271715 |
| 51 | DAPK1 | 1.10687145 |
| 52 | RAF1 | 1.08800487 |
| 53 | TAF1 | 1.07881121 |
| 54 | TTK | 1.06381673 |
| 55 | CDK9 | 1.04552956 |
| 56 | TESK1 | 1.04124322 |
| 57 | PBK | 1.03310455 |
| 58 | ALK | 1.01061449 |
| 59 | PRKCI | 0.99241496 |
| 60 | RPS6KB2 | 0.97892971 |
| 61 | AURKA | 0.94000242 |
| 62 | GRK6 | 0.92929532 |
| 63 | PNCK | 0.92776407 |
| 64 | NEK9 | 0.92626780 |
| 65 | MAP3K3 | 0.91752805 |
| 66 | TGFBR2 | 0.91140213 |
| 67 | ACVR1B | 0.90397518 |
| 68 | EIF2AK1 | 0.89555952 |
| 69 | PRPF4B | 0.89461938 |
| 70 | KDR | 0.89414439 |
| 71 | BRSK2 | 0.83788445 |
| 72 | CDK4 | 0.81588064 |
| 73 | MKNK1 | 0.81288900 |
| 74 | ABL2 | 0.78844015 |
| 75 | CDK8 | 0.77496843 |
| 76 | MAP2K3 | 0.76986236 |
| 77 | ICK | 0.76275893 |
| 78 | LATS1 | 0.75655969 |
| 79 | SCYL2 | 0.74575963 |
| 80 | GSK3A | 0.73263712 |
| 81 | TBK1 | 0.72817827 |
| 82 | NME1 | 0.72135021 |
| 83 | PDGFRB | 0.71032959 |
| 84 | GRK1 | 0.69634068 |
| 85 | CCNB1 | 0.69105593 |
| 86 | CSNK2A1 | 0.68500259 |
| 87 | MAPK4 | 0.66719392 |
| 88 | CSNK2A2 | 0.65876990 |
| 89 | PAK2 | 0.62776260 |
| 90 | DAPK2 | 0.58497837 |
| 91 | EIF2AK2 | 0.58161202 |
| 92 | CSF1R | 0.58025230 |
| 93 | PIM1 | 0.57168704 |
| 94 | CHEK2 | 0.56868168 |
| 95 | JAK3 | 0.54943619 |
| 96 | PINK1 | 0.54809853 |
| 97 | MAPKAPK5 | 0.53508295 |
| 98 | RPS6KA5 | 0.50367495 |
| 99 | DAPK3 | 0.49451478 |
| 100 | STK39 | 0.48038344 |
| 101 | PKN2 | 0.47482723 |
| 102 | RPS6KA6 | 0.47267035 |
| 103 | MAP3K1 | 0.46885966 |
| 104 | BRAF | 0.45802289 |
| 105 | ARAF | 0.45693769 |
| 106 | PDK2 | 0.45607280 |
| 107 | TAOK1 | 0.44875907 |
| 108 | TEC | 0.44056299 |
| 109 | AKT2 | 0.42382607 |
| 110 | IKBKB | 0.42171826 |
| 111 | MAP2K6 | 0.41215528 |
| 112 | MET | 0.40456013 |
| 113 | ATR | 0.39971362 |
| 114 | CHEK1 | 0.39946719 |
| 115 | CSNK1E | 0.39775199 |
| 116 | MAP3K5 | 0.38678975 |
| 117 | TGFBR1 | 0.38425302 |
| 118 | DYRK2 | 0.37971702 |
| 119 | FER | 0.37315187 |
| 120 | NEK1 | 0.37229060 |
| 121 | GRK5 | 0.35851002 |
| 122 | MTOR | 0.35780575 |
| 123 | ZAK | 0.35309583 |
| 124 | GRK7 | 0.34967530 |
| 125 | MATK | 0.34699485 |
| 126 | EGFR | 0.33649679 |
| 127 | FES | 0.31887111 |
| 128 | CDK2 | 0.30590576 |
| 129 | PAK1 | 0.30536201 |
| 130 | AKT1 | 0.30212630 |
| 131 | MAPK11 | 0.29738590 |
| 132 | ATM | 0.29645369 |
| 133 | STK4 | 0.29627879 |
| 134 | BTK | 0.29544653 |
| 135 | LATS2 | 0.29057642 |
| 136 | RPS6KL1 | 0.28919664 |
| 137 | RPS6KC1 | 0.28919664 |
| 138 | ADRBK1 | 0.27317145 |
| 139 | TNK2 | 0.25838241 |
| 140 | CDK1 | 0.24908699 |
| 141 | EEF2K | 0.24694171 |
| 142 | MAP3K6 | 0.21962681 |
| 143 | HIPK2 | 0.21417760 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.59803011 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.95735412 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.93094229 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.62733578 |
| 5 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.23886054 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 3.18269991 |
| 7 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.96974805 |
| 8 | Mismatch repair_Homo sapiens_hsa03430 | 2.87023593 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 2.67621142 |
| 10 | Pancreatic secretion_Homo sapiens_hsa04972 | 2.65416040 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 2.42898263 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.41219171 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 2.39779074 |
| 14 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.18133479 |
| 15 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.08590491 |
| 16 | Protein export_Homo sapiens_hsa03060 | 2.05519237 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.03971061 |
| 18 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.88590175 |
| 19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.78869676 |
| 20 | Cell cycle_Homo sapiens_hsa04110 | 1.69487312 |
| 21 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.68567317 |
| 22 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.68556737 |
| 23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.68292161 |
| 24 | Homologous recombination_Homo sapiens_hsa03440 | 1.60786780 |
| 25 | Sulfur relay system_Homo sapiens_hsa04122 | 1.55219866 |
| 26 | Purine metabolism_Homo sapiens_hsa00230 | 1.47620910 |
| 27 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.40863862 |
| 28 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.33221375 |
| 29 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.31015791 |
| 30 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.29290697 |
| 31 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.22753594 |
| 32 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.22582273 |
| 33 | Mineral absorption_Homo sapiens_hsa04978 | 1.22487737 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19007022 |
| 35 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.18603944 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.14712234 |
| 37 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.13567613 |
| 38 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.13005818 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.12187475 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 1.10836085 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.10295137 |
| 42 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.09833325 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.08667020 |
| 44 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.05592565 |
| 45 | RNA degradation_Homo sapiens_hsa03018 | 1.05196636 |
| 46 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.04227739 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02957847 |
| 48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.01813749 |
| 49 | Alzheimers disease_Homo sapiens_hsa05010 | 0.99677381 |
| 50 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.99266892 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.97131692 |
| 52 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.97095331 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.94290334 |
| 54 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.93160015 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.93143859 |
| 56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.90009871 |
| 57 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.89798750 |
| 58 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.89354427 |
| 59 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.88702407 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.88310008 |
| 61 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.88036823 |
| 62 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.86231774 |
| 63 | Thyroid cancer_Homo sapiens_hsa05216 | 0.83426909 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81140108 |
| 65 | Tight junction_Homo sapiens_hsa04530 | 0.80314910 |
| 66 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78992992 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75727533 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.74721958 |
| 69 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.73721986 |
| 70 | Bladder cancer_Homo sapiens_hsa05219 | 0.67643190 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.64814599 |
| 72 | Basal transcription factors_Homo sapiens_hsa03022 | 0.64076905 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62219685 |
| 74 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61790114 |
| 75 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.61368819 |
| 76 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.60839468 |
| 77 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.58517449 |
| 78 | Shigellosis_Homo sapiens_hsa05131 | 0.57137791 |
| 79 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.54700444 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52732387 |
| 81 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.50592399 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.49137970 |
| 83 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48264961 |
| 84 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.45990620 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.45942761 |
| 86 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44755233 |
| 87 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.44464062 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43455142 |
| 89 | Asthma_Homo sapiens_hsa05310 | 0.42322540 |
| 90 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.41854273 |
| 91 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.40054999 |
| 92 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.39519247 |
| 93 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.38985352 |
| 94 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38542792 |
| 95 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.38201522 |
| 96 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.37850826 |
| 97 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.37451526 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36611869 |
| 99 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.36025802 |
| 100 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.35873686 |
| 101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34860657 |
| 102 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.33677703 |
| 103 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.32269889 |
| 104 | Adherens junction_Homo sapiens_hsa04520 | 0.31739767 |
| 105 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31473128 |
| 106 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.30852739 |
| 107 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.30491217 |
| 108 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30129277 |
| 109 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29655346 |
| 110 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.29113089 |
| 111 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.28986360 |
| 112 | Retinol metabolism_Homo sapiens_hsa00830 | 0.27798990 |
| 113 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.27734656 |
| 114 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.26967373 |
| 115 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.26572892 |
| 116 | Huntingtons disease_Homo sapiens_hsa05016 | 0.24810568 |
| 117 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.24681081 |
| 118 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.24169886 |
| 119 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.23670988 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22975060 |
| 121 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.22008882 |
| 122 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21839501 |
| 123 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.21827682 |
| 124 | Apoptosis_Homo sapiens_hsa04210 | 0.21759997 |
| 125 | Pathways in cancer_Homo sapiens_hsa05200 | 0.21488812 |
| 126 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.21140337 |
| 127 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.20543602 |
| 128 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.20285472 |
| 129 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.19409380 |
| 130 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.19115974 |
| 131 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.18463311 |
| 132 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.18068041 |
| 133 | Carbon metabolism_Homo sapiens_hsa01200 | 0.17027283 |
| 134 | Lysine degradation_Homo sapiens_hsa00310 | 0.16696778 |
| 135 | Leishmaniasis_Homo sapiens_hsa05140 | 0.16211905 |
| 136 | Prostate cancer_Homo sapiens_hsa05215 | 0.15576007 |
| 137 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.15223087 |
| 138 | Legionellosis_Homo sapiens_hsa05134 | 0.14641941 |
| 139 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.14334933 |
| 140 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.14078407 |
| 141 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.12479580 |
| 142 | Influenza A_Homo sapiens_hsa05164 | 0.12155432 |

